Reports for CAELYX
Brand name CAELYX |
|---|
Company Name
BAXTER CORPORATION
|
Drug Identification Number
02238389 |
Ingredients
DOXORUBICIN HYDROCHLORIDE |
Ingredient Strength
2 MG |
ATC Code
L01DB |
ATC Descriptor
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| CAELYX | BX411008 CAELYX (Liposomal Doxorubicin), 20mg / 10mL vial | Resolved | 2024-06-06 | 2024-08-30 | 229782 |
Showing 1 to 1 of 1
Discontinuation reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0